Intravenous Cardiac Stem Cell-Derived Exosomes Ameliorate Cardiac Dysfunction in Doxorubicin Induced Dilated Cardiomyopathy

<div>(a) Outline of the<i> in vivo</i> portion of the study. Heart function analysis showing both the (b) shortening fraction and (c) ejection fraction. Both measurements of heart function showed improvement in the CSC-XO treated groups 7 days following CSC-XO injection.</div>

Stem Cells International

fig4

Figure 4

Figure 4: Intravenous Cardiac Stem Cell-Derived Exosomes Ameliorate Cardiac Dysfunction in Doxorubicin Induced Dilated Cardiomyopathy 